1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
EpiCast Report: Sepsis and Septic Shock - Epidemiology Forecast to 2026

EpiCast Report: Sepsis and Septic Shock - Epidemiology Forecast to 2026

  • August 2017
  • 61 pages
  • ID: 5082159
In this report:
In 2016, people ages ##-## years composed the highest proportion (##.##%) of in-hospital mortality cases of septic shock, followed by people ages ## years and older (##.##%).
In 2016, the US accounted for ##.##% of all septic shock in-hospital mortality cases, while Japan accounted for only ##.##% of septic shock inhospital mortality cases in the ##MM.

Summary

Table of Contents

Search Inside

EpiCast Report: Sepsis and Septic Shock - Epidemiology Forecast to 2026

Brief

Sepsis is a life-threatening complication arising from an infection, which occurs when the body's response to the infection damages its own tissues and organs. Sepsis can lead to multiple organ failure and death, especially if it is not recognized early and treated promptly (Elfeky et al., 2017; Mayo Clinic, 2016). Anyone can develop sepsis; however, the condition is more common among children less than one year of age, older adults, and those with weakened immune systems (Elfeky et al., 2017; Mayo Clinic, 2016).

In men and women, among the 7MM in 2016, the U.S. had the more significant age-standardized diagnosed incidence of sepsis and Japan (JP) had the lowest. In the 5EU (France (FR), Germany (DE), Italy (IT), Spain (ES), UK), the age-standardized diagnosed incidence of sepsis in men ranged between 94.91 cases per 100,000 population in France (FR) and 174.05 cases per 100,000 population in the United Kingdom (UK) in 2016. The age-standardized diagnosed incidence of sepsis in women in the 5EU ranged between 36.76 cases per 100,000 population in France (FR) and 128.05 cases per 100,000 populations in the United Kingdom (UK) in 2016. Due to data scarcity, the crude diagnosed incidence of sepsis for Italy (IT) is considered to be same as that of Spain and therefore the calculated age-standardized diagnosed incidence rates are also similar in these markets.

Among the 7MM, in men and women in 2016, the U.S. had the more important age-standardized diagnosed incidence of septic shock and Japan (JP) had the lowest. In the 5EU, the age-standardized diagnosed incidence of sepsis in men ranged between 29.55 cases per 100,000 population in Germany (DE) and 52.57 cases per 100,000 population in the United Kingdom (UK) in 2016. Similarly, the age-standardized diagnosed incidence of septic shock in women in the 5EU ranged between 11.56 cases per 100,000 population in France (FR) and 38.86 cases per 100,000 population in the United Kingdom (UK) in 2016. Due to data scarcity, the crude diagnosed incidence of septic shock for Italy (IT) is considered to be same as that of Spain and therefore, the calculated age-standardized diagnosed incidence rates are also similar in these markets.

The analysis "EpiCast Report: Sepsis and Septic Shock - Epidemiology Forecast to 2026", offers an overview of the risk factors, comorbidities, and the overall and historical trends for sepsis and septic shock in the seven main markets (7MM: US, France (FR), Germany (DE), Italy (IT), Spain (ES), UK, and Japan (JP)). The market research includes a 10-year epidemiological forecast for the diagnosed incident cases of sepsis and septic shock, broken down by sex and by age.

In depth, this industry report provides the following -

- The sepsis and septic shock epidemiology report is written and developed by Masters- and PhD-level epidemiologists.

- The EpiCast Report is exhaustive, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Overview

- The Sepsis and Septic Shock EpiCast Report offers an overview of the risk factors and overall trends of sepsis and septic shock in the seven main markets (7MM: US, France (FR), Germany (DE), Italy (IT), Spain (ES), UK, and Japan (JP)). It includes a 10-year epidemiological forecast for the diagnosed incident cases of sepsis and septic shock, split by age and sex. The sepsis and septic shock diagnosed incident cases are farther divided by causative agent and organ dysfunction. On top of, GlobalData epidemiologists provide a forecast for the in-hospital mortality cases of sepsis and septic shock, broken down by age for both sexes.

- The sepsis and septic shock epidemiology report is written and developed by Masters- and PhD-level epidemiologists.

- The EpiCast Report is detailed, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Great reasons to purchase

The Sepsis and Septic Shock EpiCast report will allow you to -

- Develop strategic management by understanding the trends shaping and driving the overall sepsis and septic shock market.

- Quantify patient populations in the overall sepsis and septic shock market to improve product design, pricing, and launch plans.

- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for sepsis and septic shock therapeutics in each of the markets covered.

- Comprehend the causative agent, organ dysfunction, and mortality of sepsis and septic shock.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Veronica helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Global Market Study on Adult Hemoglobinopathy Testing: HPLC Test Type to Lead in Terms of Market Share Through 2026

Global Market Study on Adult Hemoglobinopathy Testing: HPLC Test Type to Lead in Terms of Market Share Through 2026

  • $ 4900
  • Industry report
  • August 2018
  • by Persistence Market Research

This report examines the ‘Global Adult Hemoglobinopathy Testing Market’ for the period 2018–2026. The primary objective of the report is to offer updates and information related to market opportunities ...

Global Iron-deficiency Anemia Therapy Market

Global Iron-deficiency Anemia Therapy Market

  • $ 4250
  • Industry report
  • June 2018
  • by Mordor Intelligence LLP

The global iron deficiency anemia therapy market is expected to register a CAGR of 7.2% during the forecast period, 2018 to 2023. Iron deficiency anemia is caused due to the lack of iron, which is one ...

Global Medical Decision Support Systems for Sepsis Market Analysis & Trends - Industry Forecast to 2027

Global Medical Decision Support Systems for Sepsis Market Analysis & Trends - Industry Forecast to 2027

  • $ 4200
  • Industry report
  • July 2018
  • by Accuray Research LLP

The Global Medical Decision Support System for Sepsis Market is poised to grow strong during the forecast period 2017 to 2027.Some of the prominent trends that the market is witnessing include demand fo ...


ref:plp2017

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on